Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and…
sciencedirect.com
Pulmonary Progression Can be Rapid in SSc
Even in early systemic sclerosis, almost half had PAH
medpagetoday.com
SPAR Predicts ILD Progression in Systemic Sclerosis
The development and progression of interstitial lung disease in systemic sclerosis can be an…
rheumnow.com
SPAR: SpO2 <94% after 6-minute walk test + ARthritis has almost 92% predictive value for interstitial lung disease worsening in SSc.
ILD worsening at 1 year is defined as >15% drop in FVC, or, >10% drop in FVC + >15% drop in DLCO.
Response to: ‘Can we further SPARkle the SPAR model?’ by Kavadichanda et al
Thank you very much for your interest in our article ‘Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the…
ard.bmj.com
ILD in Scleroderma: Response Markers Remain Elusive
Proxies for active inflammation failed to predict cyclophosphamide…
medpagetoday.com
arthritis-research.biomedcentral.com